Advanced Feature Such As Product Quality Information, Traceability, and Reduce Product Damage Is Escalating Growth of Next-Generation Packaging Market

 

Next-Generation Packaging Market

Next-generation packaging is an advanced packaging solution that offers features such as traceability and also provides product quality information. These packaging solutions help in tracing shipments across different locations and reduce the chances of product damages. Active packaging, intelligent packaging, and modified atmosphere packaging. These solution also involve other advanced and eco-friendly process including waste disposal and air quality testing as well as the use of clean dilutions to reduce contamination.  Intelligent packaging involves the use of sensors, RFID tags, and indicators are some of the major next-generation packaging.

The rising demand for efficient packaging solutions among consumers is fueling the growth of the next-generation packaging market. Increasing advancement in the packaging materials coupled with the growing need for sustainable packaging techniques is again expected to foster market growth. Moreover, the growing adoption of advanced sensors and QR codes is also fostering the growth of next-generation packaging market. The advent of active packaging, intelligent packaging, and modified atmosphere packaging is projected to support the growth of the next generation packaging market. Furthermore, the growing need for traceability, product shelf life extension, and product quality information is further anticipated to propel the growth of the next-generation packaging market over the forecast period.

North America is expected to gain significant growth over the forecast timeframe and this is attributed to the continuous launch of innovative products in the region. For instance, in November 2020, Argha Films Announces U.S. Launch of BOPP Film at PACK EXPO 2020. Arlene, a biaxially oriented polypropylene film, has been used by flexible packaging manufacturers in 60+ countries worldwide for nearly 4 decades.

Key Developments:

1.     In August 2020, Avery Dennison Label and Packaging Materials have launched Global MDO Next Generation, a semi-squeeze film that offers enhanced clarity, conformability, and sustainability.

2.     In August 2020, Syntegon has introduced its next generation of heat sealing flow wrappers called Pack 202 to the North American market. The new machine is a fully automated horizontal flow wrapping machine for low to medium speeds.

3.     In August 2020, Ranpak Holdings Corp. a global provider of environmentally sustainable, paper-based packaging solutions for e-commerce and industrial supply chains, today announced the North American launch of the next generation of its AccuFill® automation technology.

4.     In September 2019, Sonoco the sustainable, diversified global packaging company announced the creation of its new EnviroSense™ sustainable packaging initiative.

 

 

 

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the deman
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cance
Read more